Skip to main content
Quest Diagnostics

Tick-borne Illness: A Panel Discussion About Emerging Diagnostic Insights - 2021

Description: A panel discussion about tick-borne illnesses: emerging diagnostic insights, presented by Dr Hema Kapoor, Dr Meghan Starolis, Dr Tara Givens, and Dr Robert Jones; moderated by Dr Ann Salm

 

Learning objectives:

 - Differentiate the best-use cases for PCR vs serology testing

 - Understand the clinical application of newly launched tick-borne tests

 - Determine the clinical implications of CPVID-19 on tick-borne illness, diagnosis, and prevalence

 

Date:
Jun 18, 2021
Presenter(s):
Tara Givens, PhD
Robert Jones, DO, MS, FACP, FIDSA, CPE
Hema Kapoor, MD, SM, D(ABMM)
Meghan Starolis
Moderator(s):
Ann Salm, M (ASCP)CM, MS, PhD

Related content

Publication
Utility and recommendations for the use of multiplex molecular gastrointestinal pathogen panels
Publication
A Comparison of Lyme Serological Testing Platforms with a Panel of Clinically Characterized Samples from Various Stages of Lyme Disease
On-Demand Webinar
Tick-borne Illness A Panel Discussion About Emerging Diagnostics Insights
Test FAQ
Lyme Disease Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.